Zoster Eye Disease Study

NCT03134196 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

527

Enrollment

OTHER

Sponsor class

Conditions

Herpes Zoster Ophthalmicus

Interventions

DRUG: Masked Placebo
DRUG: Masked Oral Valacyclovir

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]